MARKET WIRE NEWS

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-13 14:29:05 ET

Humacyte, Inc. (HUMA)

Q1 2025 Earnings Conference Call

May 13, 2025 08:30 AM ET

Company Participants

Thomas Johnson - Director-Corporate Communications, LifeSci Advisors, IR

Laura Niklason - Founder, President and Chief Executive Officer

Dale Sander - Chief Financial Officer, Chief Corporate Development Officer and Treasurer

BJ Scheessele - Chief Commercial Officer

Conference Call Participants

Ryan Zimmerman - BTIG

Josh Jennings - TD Cowen

Kristen Kluska - Cantor Fitzgerald

Bruce Jackson - Benchmark Company

Presentation

Operator

Good morning, ladies and gentlemen and welcome to the Humacyte's First Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer sessions, instructions will follow at that time. As a reminder, this conference is being recorded....

Read the full article on Seeking Alpha

For further details see:

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript
Humacyte Inc. Warrant

NASDAQ: HUMAW

HUMAW Trading

0.02% G/L:

$0.107 Last:

200 Volume:

$0.10698 Open:

mwn-link-x Ad 300

HUMAW Latest News

HUMAW Stock Data

$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App